Le Lézard
Classified in: Health
Subject: ATY

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 5, 2024 in Agenus Lawsuit - AGEN


NEW YORK, Sept. 20, 2024 /PRNewswire/ --, September 20, 2024 ? Levi & Korsinsky, LLP notifies investors in Agenus Inc. ("Agenus" or the "Company") (NASDAQ: AGEN) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Agenus investors who were adversely affected by alleged securities fraud between January 23, 2023 and July 17, 2024. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/agenus-lawsuit-submission-form?prid=103785&wire=4

AGEN investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) the combination therapy of their immuno-oncology products, botensilimab and balstilimab was less effective than the defendants had led investors to believe; (ii) accordingly, botensilimab and balstilimab's clinical results, as well as their regulatory and commercial prospects, were overstated; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

WHAT'S NEXT? If you suffered a loss in Agenus during the relevant time frame, you have until November 5, 2024 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP


These press releases may also interest you

at 14:32
Evenly Technologies, the AI-enabled telemedicine company revolutionizing orthodontic care, is thrilled to announce its recognition as one of LinkedIn's 2024 Top Startups. This accolade highlights Evenly's fast-paced growth, industry-leading...

at 14:18
Today, MyHealthTeam, creator of the largest and fastest-growing social networks for people facing chronic health conditions, proudly announced the launch of myHIVteam in Spanish. This initiative marks a significant milestone in improving health...

at 14:08
MDisrupt, the premier expert marketplace for the...

at 14:05
Today, the Scott-Morgan Foundation (SMF), a pioneering non-profit in assistive technology innovation, unveiled a groundbreaking AI-powered solution to transform the lives of people with amyotrophic lateral sclerosis (ALS) and other severe...

at 14:03
Medicare Advantage+Part D plans in 47 states and Puerto Rico will be recognized for exceptional value in the design of their medical and Part D prescription drug benefits available effective January 1. The 2025 Senior Choice Gold Award recipients...

at 14:00
Exelixis, Inc. today announced that in the lawsuit Exelixis, Inc. (Exelixis) vs. MSN Laboratories Private Limited et al. (MSN), Civil Action No. 22-00228 (Consolidated), the U.S. District Court for the District of Delaware ruled in Exelixis' favor,...



News published on and distributed by: